AdaptHealth (TICKER: AHCO) Benchmark And Performance Data

there are 11 of samples in the benchmark for AdaptHealth in year 2022 in 2022. The total inventory for AdaptHealth was $58,783,000.00 in 2020. The total inventory for AdaptHealth was $13,239,000.00 in 2019. The total inventory for AdaptHealth was $123,095,000.00 in 2021. The total inventory for AdaptHealth was $0.00 in 2018. The sales, general, and administrative (SGA) for AdaptHealth was $89,346,000.00 in 2020. The sales, general, and administrative (SGA) for AdaptHealth was $56,493,000.00 in 2019. The sales, general, and administrative (SGA) for AdaptHealth was $167,505,000.00 in 2021. The sales, general, and administrative (SGA) for AdaptHealth was $1,036,124.00 in 2018. The sales, general, and administrative (SGA) for AdaptHealth was $$162,000,000 in 2022. The revenue volatility for AdaptHealth was 80.77% in 2022. The market capitalization for AdaptHealth was $2,589,542,601.00 in 2018. The market capitalization for AdaptHealth was $1,667,460,025.00 in 2019. The market capitalization for AdaptHealth was $1,637,077,317.00 in 2020. The market capitalization for AdaptHealth was $1,238,564,691.00 in 2021. The market capitalization for AdaptHealth was $$947,000,000 in 2022. The gross revenue for AdaptHealth was $529,644,000.00 in 2019. The gross revenue for AdaptHealth was $2,454,535,000.00 in 2021. The gross revenue for AdaptHealth was $1,056,389,000.00 in 2020. The gross revenue for AdaptHealth was $0.00 in 2018. The gross revenue for AdaptHealth was $$2,971,000,000 in 2022. The gross margin for AdaptHealth was $6.41% in 2022. The days sales outstanding for AdaptHealth was 44 days in 2022. The days payable outstanding for AdaptHealth was 34 days in 2022. The days of inventory for AdaptHealth was $18 in 2022. The cost of goods sold (COGS) for AdaptHealth was 85.95% in 2022. The cost of goods sold (COGS) for AdaptHealth was $898,601,000.00 in 2020. The cost of goods sold (COGS) for AdaptHealth was $440,705,000.00 in 2019. The cost of goods sold (COGS) for AdaptHealth was $2,008,925,000.00 in 2021. The cost of goods sold (COGS) for AdaptHealth was $$2,553,000,000 in 2022. The cash to cash cycle time for AdaptHealth was 28 in 2022. The annual percentage growth rate of AdaptHealth was -0.21% in 2022. AdaptHealth in its benchmark peer group, had rank 8 for gross revenue in 2022. AdaptHealth in its benchmark peer group, had rank 2 days for days sales outstanding in 2022. AdaptHealth in its benchmark peer group, had rank 11 for cost of goods sold as a percent of revenue in 2022. AdaptHealth in its benchmark peer group, had rank 10 for sales growth in 2022. AdaptHealth in its benchmark peer group, had rank 1 for cash to cash cycle time in 2022. AdaptHealth in its benchmark peer group, had rank 1 days for days of inventory in 2022. AdaptHealth headquarters region is East. AdaptHealth has ticker symbol AHCO. AdaptHealth has the following profile: AdaptHealth Corp. , together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States.. AdaptHealth has primary indstury Medical Devices. AdaptHealth had a $$764,000,000 gap between actual performance and next performance rank for gross revenue in competitive benchmarking in 2022. AdaptHealth had Abbott Laboratories, and QuidelOrtho, and Zimmer Biomet, and Edwards Lifesciences, and Bio-Rad Laboratories, and Boston Scientific, and Align Technology, and Stryker, and AdaptHealth, and Bruker, and DexCom benchmark peer companies for its SIC code in 2022. AdaptHealth had 67.45% gap between actual performance and next performance rank for sales volatility in competitive benchmarking in 2022. AdaptHealth had 48.70% gap between actual performance and next performance rank for cost of goods sold as a percent of revenue in competitive benchmarking in 2022. AdaptHealth had 10.77% gap between actual performance and next performance rank for gross margin in competitive benchmarking in 2022. AdaptHealth had 0.16% gap between actual performance and next performance rank for sales growth in competitive benchmarking in 2022. AdaptHealth had 0 days gap between actual performance and next performance rank for days sales outstanding in competitive benchmarking in 2022. AdaptHealth had 0 days gap between actual performance and next performance rank for days of inventory in competitive benchmarking in 2022. AdaptHealth had 0 days gap between actual performance and next performance rank for cash to cash in competitive benchmarking in 2022. AdaptHealth had - number of employees in 2022. AdaptHealth can reduce overall cost by $$1,447,000,000 by improving both COGS and SGA to next benchmark tier in 2022. AdaptHealth can reduce inventory with practices including in 2022. AdaptHealth can reduce days sales outstanding with practices including in 2022. AdaptHealth can increase sales revenue by $$764,000,000 improving sales performance to next benchmark tier in 2022. AdaptHealth can increase revenue growth by $$5,000,000 by improving growth performance to next benchmark tier in 2022. AdaptHealth can increase overall revenue by $$769,000,000 by improving both growth and sales performance to next benchmark tier in 2022. AdaptHealth can increase days payables outstanding with practices including Strategic Sourcing in 2022. AdaptHealth can increase days payables outstanding by $212,000,000 days by increasing days payables outstanding to next benchmark tier in 2022. AdaptHealth can improve total financial performance by $$2,427,000,000 by improving revenue, costs, and working capital in 2022. AdaptHealth can decrease overall working capital by $$212,000,000 by improving inventory, payables and receivables to next benchmark tier in 2022. AdaptHealth can decrease inventory days by $0 days by reducing inventory days to next benchmark tier in 2022. AdaptHealth can decrease days sales outstanding by $0 days by reducing days sales outstanding to next benchmark tier in 2022. AdaptHealth can accelerate revenue growth practices including Revenue-optimized Planning in 2022. AdaptHealth can accelerate revenue growth practices including Pricing Optimization in 2022. AdaptHealth can accelerate revenue growth practices including Accelerate Design Pipeline in 2022. 94 days was the measured superior or top ten performance level for days of inventory in AdaptHealth's peer group in 2022. 9.89% was the measured superior or top ten performance level for sales volatility in AdaptHealth's peer group in 2022. 75 days was the measured superior or top ten performance level for cash to cash cycle time in AdaptHealth's peer group in 2022. 60 days was the measured parity or middle performance level for days sales outstanding in AdaptHealth's peer group in 2022. 53 days was the measured advantage or top third performance level for days sales outstanding in AdaptHealth's peer group in 2022. 44 days was the measured superior or top ten performance level for days sales outstanding in AdaptHealth's peer group in 2022. 37.24% was the measured parity or middle performance level for cost of goods sold as a percent of revenue in AdaptHealth's peer group in 2022. 31.56% was the measured advantage or top third performance level for cost of goods sold as a percent of revenue in AdaptHealth's peer group in 2022. 30.00% was the measured superior or top ten performance level for gross margin in AdaptHealth's peer group in 2022. 29.10% was the measured superior or top ten performance level for cost of goods sold as a percent of revenue in AdaptHealth's peer group in 2022. 159 days was the measured parity or middle performance level for days of inventory in AdaptHealth's peer group in 2022. 138 days was the measured parity or middle performance level for cash to cash cycle time in AdaptHealth's peer group in 2022. 13.32% was the measured parity or middle performance level for sales volatility in AdaptHealth's peer group in 2022. 119 days was the measured advantage or top third performance level for cash to cash cycle time in AdaptHealth's peer group in 2022. 11.40% was the measured advantage or top third performance level for sales volatility in AdaptHealth's peer group in 2022. 108 days was the measured advantage or top third performance level for days of inventory in AdaptHealth's peer group in 2022. 0.04% was the measured superior or top ten performance level for sales growth in AdaptHealth's peer group in 2022. -0.05% was the measured parity or middle performance level for sales growth in AdaptHealth's peer group in 2022. -0.02% was the measured advantage or top third performance level for sales growth in AdaptHealth's peer group in 2022. $18.02% was the measured advantage or top third performance level for gross margin in AdaptHealth's peer group in 2022. $17.18% was the measured parity or middle performance level for gross margin in AdaptHealth's peer group in 2022. $$6,940,000,000 was the measured advantage or top third performance level for gross revenue in AdaptHealth's peer group. $$3,735,000,000 was the measured parity or middle performance level for gross revenue in AdaptHealth's peer group in 2022. $$18,449,000,000 was the measured superior or top ten performance level for gross revenue in AdaptHealth's peer group in 2022.